HighlightsRSS Feed
Daniel Kastner

NHGRI Scientific Director Dan Kastner elected to the Institute of Medicine

Daniel L. Kastner, M.D., Ph.D., scientific director of the National Human Genome Research Institute (NHGRI), has been elected to the Institute of Medicine (IOM), one of the highest honors in the fields of health and medicine.
Read more

Human figures

President's bioethics commission releases report on genomics and privacy

Genomics and privacy are the focus of a new report released today by the Presidential Commission for the Study of Bioethical Issues. The report, which includes a dozen recommendations, concludes that individual interests in privacy must be respected and secured to realize the enormous promise that whole genome sequencing holds for advancing clinical care. Read more

Slit-lamp photographs show the cornea of a three-year-old patient with nephropathic cystenosis.

FDA approves crystal-dissolving eye drops, a major milestone for NIH rare disease researchers

Read the heroic story of how an experimental eye-drop solution containing a drug called cysteamine eliminates the painful and destructive crystalline shards in the eyes of patients suffering from a rare, inherited condition called nephropathic cystinosis. Learn how the eyedrop went from clinical trial, to FDA approval and availability for use on Oct. 3, 2012, The research was spearheaded by NHGRI Clinical Director, William Gahl, M.D., Ph.D.
Read more

Genome Advance of the Month
Klebsiella bacteria

Whole genome sequencing used to track infection's transmission path

Using whole bacterial genome sequencing to trace the transmission of a hospital-acquired infection is this month's Genome Advance of the Month, a potentially important breakthrough for hospital epidemiology. . Read more

View Highlights Archive

For You
NewsroomRSS Feed
GenomeTVView All
Quick Links